| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 34 |
| 1 | METHOTREXATE | 31 |
| 2 | DUPILUMAB | 27 |
| 3 | RITUXIMAB | 23 |
| 4 | DEXAMETHASONE | 20 |
| 5 | PREDNISONE | 20 |
| 6 | ERGOCALCIFEROL | 17 |
| 7 | DEXAMETHASONE 1.5 MG | 16 |
| 8 | METHYLPREDNISOLONE | 16 |
| 9 | INFLIXIMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISMUTH SUBGALLATE | 1 | 0.0217 |
| 1 | SARECYCLINE HYDROCHLORIDE | 1 | 0.0050 |
| 2 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 3 | CYSTEAMINE HYDROCHLORIDE | 2 | 0.0030 |
| 4 | INFLIXIMAB-DYYB | 10 | 0.0029 |
| 5 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | 1 | 0.0022 |
| 6 | ALCAFTADINE | 2 | 0.0022 |
| 7 | CYSTEAMINE BITARTRATE | 2 | 0.0019 |
| 8 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 9 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 2 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 59 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 31 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 27 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 26 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 25 |
| 6 | Vitamin C [EPC] | 18 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 8 | Vitamin B12 [EPC] | 16 |
| 9 | Vitamin D [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 1 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 2 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 3 | Interleukin-13 Antagonist [EPC] | 2 | 0.0003 |
| 4 | Ectoparasiticide [EPC] | 1 | 0.0003 |
| 5 | Antiseptic [EPC] | 1 | 0.0002 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Bismuth [EPC] | 1 | 0.0002 |
| 8 | Carbonic Anhydrase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |